{"DataElement":{"publicId":"2431563","version":"1","preferredName":"Other Breast Cancer Histopathologic Grade Score Integer","preferredDefinition":"The number from 1-3 indicating the histopathologic grade in invasive breast carcinoma, when the histopathologic grading of the invasive breast carcinoma is performed using a system other than the Nottingham system.","longName":"2431357v1.0:2435614v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431357","version":"1","preferredName":"Other Invasive Breast Carcinoma Histopathologic Grade Score","preferredDefinition":"Different than the one(s) previously specified or mentioned.:A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior_A number or range of numeric values measuring performance, function, quality, or ability.","longName":"2431282v1.0:2322175v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431282","version":"1","preferredName":"Other Invasive Breast Carcinoma Histopathologic Grade","preferredDefinition":"Different than the one(s) previously specified or mentioned.:A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior","longName":"C17649:C9245:C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF287-1586-3AE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322175","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-04B2-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-02","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-08-02","modifiedBy":"ONEDATA","dateModified":"2005-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE0323-552E-41A6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Permission to Release DEC granted by primary curator in 8/2008.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2435614","version":"1","preferredName":"Other Breast Cancer Histopathologic Grade Score Integer","preferredDefinition":"A number with no fractional part.","longName":"2435614v1","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Grade 1 (Other grading system)","ValueMeaning":{"publicId":"2577269","version":"1","preferredName":"Grade 1 (Other grading system)","longName":"2577269","preferredDefinition":"Grade 1 (Other grading system)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FAE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CROWLEYR","dateModified":"2005-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"06F397CB-43C6-08F1-E044-0003BA3F9857","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CROWLEYR","dateModified":"2005-12-09","deletedIndicator":"No"},{"value":"2","valueDescription":"Grade 2 (Other grading system)","ValueMeaning":{"publicId":"2577270","version":"1","preferredName":"Grade 2 (Other grading system)","longName":"2577270","preferredDefinition":"Grade 2 (Other grading system)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FAE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CROWLEYR","dateModified":"2005-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"06F397CB-43C7-08F1-E044-0003BA3F9857","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CROWLEYR","dateModified":"2005-12-09","deletedIndicator":"No"},{"value":"3","valueDescription":"Grade 3 (Other grading system)","ValueMeaning":{"publicId":"2577271","version":"1","preferredName":"Grade 3 (Other grading system)","longName":"2577271","preferredDefinition":"Grade 3 (Other grading system)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FAE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CROWLEYR","dateModified":"2005-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP Cancer Protocols","id":"06F397CB-43C8-08F1-E044-0003BA3F9857","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CROWLEYR","dateModified":"2005-12-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433737","version":"1","preferredName":"Integer","preferredDefinition":"A number with no fractional part.","longName":"C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4769-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-25","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-25","modifiedBy":"ONEDATA","dateModified":"2005-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06F397CB-43B0-08F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-09","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-12-09","modifiedBy":"CURTIST","dateModified":"2010-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2180031","version":"1","longName":"GF4057 Test (production)","context":"TEST","ClassificationSchemeItems":[{"publicId":"2812514","version":"1","longName":"4th level in hierarchy","context":"TEST"}]},{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000562","version":"1","longName":"edu.pitt.cabig.cae.domain.breast","context":"NCIP"}]},{"publicId":"2857187","version":"1","longName":"CAP Cancer Checklists","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812063","version":"1","longName":"edu.upmc.opi.cabig.caties.cap.domain.breast","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.breast.OtherBreastCancerHistologicGrade.score","type":"UML Qualified Attr","context":"NCIP"},{"name":"OtherBreastCancerHistologicGrade:score","type":"UML Class:UML Attr","context":"NCIP"},{"name":"OtherBreastCancerHistopathologicGrade:score","type":"UML Class:UML Attr","context":"NCIP"},{"name":"edu.upmc.opi.cabig.caties.cap.domain.breast.OtherBreastCancerHistopathologicGrade.score","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Other Grading System Grade","type":"Preferred Question Text","description":"Other Grading System Grade","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE591A-64CA-5B60-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}